EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Camel Milk-Derived Peptide LLPK Improves Glucose-Lipid Metabolism in db/db Mice via PPAR Signaling Pathway

Binsong Han, Yuhui Ye iD, Cunzheng Zhang iD, Lina Zhang iD, Peng Zhou

Nutrients · 2025

DOI: 10.3390/nu17101693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Binsong Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Food Saf…. Hauptthemen laut MEDLINE: Milk, Blood Glucose, Lipid Metabolism, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Jiangsu Funding Program for Excellent Postdoctoral Talent, National Natural Science Foundation of China, Jiangsu Innovative and Entrepreneurial Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Camel milk is considered to be an important source of bioactive peptides with potential anti-diabetic effects. However, the mechanism by which these active peptides exert their anti-diabetic effects is not clear. The aim of this study was to systematically evaluate the in vivo anti-diabetic effects of Leucine-Leucine-Proline-Lysine (LLPK), a novel dipeptidyl peptidase-4 (DPP-4) inhibitory peptide identified from the in vitro gastrointestinal digestion product of camel milk.

Methods

A db/db diabetic mouse model was used, and LLPK was administered to mice at doses of 50 mg/kg BW and 100 mg/kg BW as a daily oral gavage for 30 days. The effects of LLPK on fasting blood glucose (FBG), oral glucose tolerance test (OGTT), insulin tolerance test (ITT), and serum lipid levels were monitored, and possible mechanisms of action were elucidated using proteomics.

Results

The results demonstrated that LLPK significantly improved diabetic symptoms, including FBG, OGTT, ITT, and serum lipid levels in db/db diabetic mice. Furthermore, significantly increased levels of serum glucagon-like peptide 1 (GLP-1) and reduced serum DPP-4 activity were observed in the LLPK-treated group compared to the control group. Hepatic proteomics indicated that LLPK improved glucose and lipid metabolism via the PPAR signaling pathway, where the key targets were Scd1, Acox1, Acaa1b, Slc27a1, Acsl1, and Ehhadh.

Conclusions

In summary, this study provided new insights into the anti-diabetic mechanisms of camel milk and supported the development of camel milk-based anti-diabetic functional foods or nutraceuticals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MilkBlood GlucoseLipid MetabolismDiabetes Mellitus, ExperimentalPeroxisome Proliferator-Activated ReceptorsHypoglycemic AgentsPeptidesDiabetes Mellitus, Type 2AnimalsCamelusMiceSignal TransductionMaleGlucagon-Like Peptide 1Glucose Tolerance TestMice, Inbred C57BLDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsInsulin

Stichwörter der Autor:innen

PPAR signaling pathwaycamel milk-derived peptidediabeteshepatic proteome

Substanzen

Blood GlucoseGlucagon-Like Peptide 1Peroxisome Proliferator-Activated ReceptorsHypoglycemic AgentsDipeptidyl Peptidase 4PeptidesDipeptidyl-Peptidase IV InhibitorsInsulin

Autor:innen und Institutionen

  • Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Food Safety and Nutrition, Jiangsu Academy of Agricultural Sciences, Nanjing 2…
  • School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
  • International Joint Research Laboratory for Dairy Science and Technology, Jiangnan University, Wuxi 214122, China.

ORCID-Profile: Yuhui Ye, Cunzheng Zhang, Lina Zhang

Förderung

  • the Jiangsu Funding Program for Excellent Postdoctoral Talent
  • National Natural Science Foundation of China
  • Jiangsu Innovative and Entrepreneurial Talents Program
  • Nanjing Science and Technology Innovation Project
  • Jiangsu Funding Program for Excellent Postdoctoral Talent

Zitieren

APA

Han, B., Ye, Y., Zhang, C., Zhang, L., & Zhou, P. (2025). A Novel Camel Milk-Derived Peptide LLPK Improves Glucose-Lipid Metabolism in db/db Mice via PPAR Signaling Pathway. Nutrients. https://doi.org/10.3390/nu17101693

Vancouver

Han B, Ye Y, Zhang C, Zhang L, Zhou P. A Novel Camel Milk-Derived Peptide LLPK Improves Glucose-Lipid Metabolism in db/db Mice via PPAR Signaling Pathway. Nutrients. 2025. doi:10.3390/nu17101693

BibTeX
@article{Han2025,
  author = {Han, Binsong and Ye, Yuhui and Zhang, Cunzheng and Zhang, Lina and Zhou, Peng},
  title = {A Novel Camel Milk-Derived Peptide LLPK Improves Glucose-Lipid Metabolism in db/db Mice via PPAR Signaling Pathway},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17101693}
}
Kostenlos starten →